We are live on ! Find out more
BGA

Belmont Global Advisors Portfolio holdings

AUM $106M
1-Year Est. Return 2.89%
This Fund
S&P 500
This Quarter Est. Return
-14.18%
1 Year Est. Return
-2.89%
3 Year Est. Return
+81.05%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$58.9M
AUM Growth
-$31.3M
Cap. Flow
-$19.4M
Cap. Flow %
-32.94%
Top 10 Hldgs %
57.22%
Holding
101
New
5
Increased
16
Reduced
12
Closed
48

Top Buys

Rank Stock Value
1
TOVX icon
Theriva Biologics
TOVX
+$1.55M
2
BMY icon
Bristol-Myers Squibb
BMY
+$952K
3
GNMX
Aevi Genomic Medicine Inc
GNMX
+$921K
4
GILD icon
Gilead Sciences
GILD
+$777K
5
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$768K

Top Sells

Rank Stock Value
1
VVR icon
Invesco Senior Income Trust
VVR
+$2.29M
2
MLPN
Credit Suisse X- Links Cushing MLP Infrastructure ETN's due April 20, 2020
MLPN
+$1.44M
3
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$1.31M
4
RSPG icon
Invesco S&P 500 Equal Weight Energy ETF
RSPG
+$1.3M
5
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$1.23M

Sector Composition

Rank Sector Weight
1 Healthcare 47.67%
2 Consumer Discretionary 8.89%
3 Financials 7.06%
4 Consumer Staples 5.84%
5 Technology 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TCRT icon
1
Alaunos Therapeutics
TCRT
$4.69M
$12.4M 21.12%
9,207
-641
-7% -$1.06M
PGEN icon
2
Precigen
PGEN
$1.98B
$5.48M 9.3%
173,800
+1,311
+0.8% +$64K
TCRT icon
3
CALL
Alaunos Therapeutics
TCRT
$4.69M
$3.6M 6.12%
2,667
+1,295
+94% +$2.14M
WWAV
4
DELISTED
The WhiteWave Foods Company
WWAV
$2.81M 4.77%
70,000
– –
HEDJ icon
5
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.8B
$2.13M 3.62%
78,000
-4,000
-5% -$120K
GILD icon
6
Gilead Sciences
GILD
$162B
$1.67M 2.83%
17,000
+7,000
+70% +$777K
FBIO icon
7
Fortress Biotech
FBIO
$114M
$1.56M 2.65%
40,000
-12,087
-23% -$565K
VBTX
8
DELISTED
Veritex Holdings
VBTX
$1.43M 2.42%
91,229
+26,229
+40% +$418K
PDI icon
9
PIMCO Dynamic Income Fund
PDI
$7.42B
$1.31M 2.22%
45,340
– –
SBUX icon
10
Starbucks
SBUX
$118B
$1.28M 2.17%
22,500
– –
TOVX icon
11
Theriva Biologics
TOVX
$9.96M
$1.25M 2.12%
+63
New +$1.55M
GNMX
12
DELISTED
Aevi Genomic Medicine Inc
GNMX
$1.21M 2.06%
155,000
+118,800
+328% +$921K
XLY icon
13
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.3B
$1.11M 1.89%
30,000
+20,000
+200% +$768K
ORLY icon
14
O'Reilly Automotive
ORLY
$71.4B
$1M 1.7%
60,000
+36,750
+158% +$593K
LJPC
15
DELISTED
La Jolla Pharmaceutical Company
LJPC
$973K 1.65%
35,000
-15,000
-30% -$473K
BHC icon
16
Bausch Health
BHC
$1.66B
$892K 1.51%
5,000
– –
BMY icon
17
Bristol-Myers Squibb
BMY
$126B
$888K 1.51%
+15,000
New +$952K
DIS icon
18
Walt Disney
DIS
$161B
$764K 1.3%
7,478
+2,500
+50% +$272K
DYAX
19
DELISTED
DYAX CORPORATION
DYAX
$764K 1.3%
40,000
+25,000
+167% +$597K
AVGO icon
20
Broadcom
AVGO
$1.87T
$750K 1.27%
60,000
-22,500
-27% -$284K
MLPL
21
DELISTED
UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN
MLPL
$735K 1.25%
30,000
+14,000
+88% +$490K
UAA icon
22
Under Armour
UAA
$2.87B
$726K 1.23%
15,106
– –
LNG icon
23
Cheniere Energy
LNG
$57B
$724K 1.23%
15,000
+5,500
+58% +$339K
AGN
24
DELISTED
Allergan plc
AGN
$680K 1.15%
2,500
– –
NKE icon
25
Nike
NKE
$60.8B
$646K 1.1%
10,500
– –
1
2 3 4 5

Similar funds

LOT
Lombard Odier Transatlantic Montreal, Quebec, Canada $105M AUM 10.28% 1-Year Est. Return
EC
Eachwin Capital New York $108M AUM 14.45% 1-Year Est. Return
SAMNY
Samsung Asset Management (New York) New York $109M AUM 14.34% 1-Year Est. Return
DCMM
DG Capital Management (Massachusetts) Boston, Massachusetts $102M AUM 29.14% 1-Year Est. Return
PCM
Panning Capital Management New York $97.5M AUM 302.5% 1-Year Est. Return
SVGI
Sapphire Ventures (GPE) I Palo Alto, California $115M AUM 11.63% 1-Year Est. Return
EDRM
Edmond de Rothschild (Monaco) Monaco $116M AUM
EDRAML
Edmond de Rothschild Asset Management (Luxembourg) Luxembourg $95.2M AUM 19.45% 1-Year Est. Return

Belmont Global Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Belmont Global Advisors held 101 positions worth $58.9M, down 35% from $90.2M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Belmont Global Advisors withdrew a net $19.4M in Q3 2015, closing 48 positions and reducing 12 holdings. Its most notable exit was Invesco Senior Income Trust, an estimated $2.29M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 40% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Belmont Global Advisors opened a new position in Theriva Biologics worth $1.25M.

  • Belmont Global Advisors's largest Q3 2015 buy was Theriva Biologics: 63 shares worth $1.25M.
  • Belmont Global Advisors added most to Aevi Genomic Medicine Inc in Q3 2015, an estimated $921K increase.
  • Belmont Global Advisors's biggest Q3 2015 reduction was Alaunos Therapeutics, cutting an estimated $1.06M.
  • Belmont Global Advisors fully exited Invesco Senior Income Trust in Q3 2015, selling an estimated $2.29M.
  • Belmont Global Advisors's ten largest holdings make up 57% of its $58.9M portfolio in Q3 2015.
  • Belmont Global Advisors opened 5 new positions and closed 48 in Q3 2015.
  • Belmont Global Advisors's portfolio value fell 35% quarter-over-quarter to $58.9M.

Based on Belmont Global Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.